Table 2.
Clinicopathological characteristics of pancreatic cancer patients selected for MUC4 staining.
| Variable | PDAC + OJ (n = 25) | PDAC (n = 25) | NE (n = 11) | NORMAL (n = 4) | ||||
|---|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | n | (%) | n | (%) | |
| Gender | ||||||||
| Male | 13 | (52.0) | 17 | (68.0) | 8 | (72.7) | 1 | (25.0) |
| Female | 12 | (48.0) | 8 | (32.0) | 3 | (27.3) | 3 | (75.0) |
| Age | ||||||||
| ˂ 65 | 6 | (24.0) | 10 | (40.0) | 4 | (36.36) | 4 | (100.0) |
| ≥ 65 | 19 | (76.0) | 15 | (60.0) | 7 | (63.64) | 0 | (0.0) |
| Location of primary tumor | ||||||||
| Papilla of Vater | 3 | (12.0) | 0 | (0.0) | 0 | (0.0) | ||
| Head | 22 | (88.0) | 18 | (72.0) | 6 | (54.54) | ||
| Head/Body | 0 | (0.0) | 5 | (20.0) | 0 | (0.0) | ||
| Body | 0 | (0.0) | 1 | (4.0) | 1 | (9.1) | ||
| Tail | 0 | (0.0) | 1 | (4.0) | 4 | (36.36) | ||
| Hystological type | ||||||||
| Well differentiated | 3 | (12.0) | 3 | (12.0) | 4 | (36.37) | ||
| Moderately differentiated | 12 | (48.0) | 18 | (72.0) | 7 | (63.63) | ||
| Poorly differentiated | 10 | (40.0) | 4 | (16.0) | 0 | (0.0) | ||
| Stage of the cancer | ||||||||
| II | 2 | (8.0) | 4 | (16.0) | 8 | (72.73) | ||
| III | 10 | (40.0) | 12 | (48.0) | 3 | (27.27) | ||
| IV | 13 | (52.0) | 9 | 36.0) | ||||
| Lymphatic invasion | ||||||||
| Negative | 17 | (68.0) | 20 | (80.0) | 11 | (100.0) | ||
| Positive | 8 | (32.0) | 5 | (20.0) | 0 | (0.0) | ||
| Metastasis | ||||||||
| Lung | 2 | (8.0) | 4 | (16.0) | 0 | (0.0) | ||
| Liver | 6 | (24.0) | 10 | (40.0) | 2 | (18.18) | ||
| Colon | 0 | (0.0) | 2 | (8.0) | 0 | (0.0) | ||
| Gall bladder | 1 | (4.0) | 0 | (0.0) | 0 | (0.0) | ||